Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...

Endeavour Silver (NYSE:EXK) has announced a bought deal financing with a syndicate of underwriters to raise gross proceeds of approximately US$73M. The underwriters, led by BMO Capital Markets, have ...